Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Larson

Showing results (741-750 of 798) with videos related to

Pageof 80
Sort By:
Plos One|January 30, 2010
Risk of ovarian cancer and inherited variants in relapse-associated genesAbraham Peedicayil, Robert A Vierkant, Lynn C Hartmann, et al.
Research Square|April 24, 2023
Vaccination with intravenous BCG protects macaques with pre-existing SIV infection from tuberculosisErica C Larson, Amy L Ellis-Connell, Mark A Rodgers, et al.
Blood|July 12, 2019
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemiaBrian Giacopelli, Qiuhong Zhao, Amy S Ruppert, et al.
Blood Cancer Journal|April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genesNicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Molecular Genetics & Genomic Medicine|September 26, 2017
Targeted sequencing of 36 known or putative colorectal cancer susceptibility genesMelissa S DeRycke, Shanaka Gunawardena, Jessica R Balcom, et al.
Blood Advances|February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort StudyJia Ruan, Zhengming Chen, Melissa C Larson, et al.
American Journal of Hematology|February 7, 2025
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort StudySamuel Yamshon, Jean L Koff, Melissa C Larson, et al.
Nature|September 24, 2025
In vivo CRISPR screens identify modifiers of CAR T cell function in myelomaNelson H Knudsen, Giulia Escobar, Felix Korell, et al.
Cell Reports. Medicine|January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancerDongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Pageof 80

Showing results (741-750 of 798) with videos related to

Sort By:
Pageof 80
Plos One|January 30, 2010
Risk of ovarian cancer and inherited variants in relapse-associated genesAbraham Peedicayil, Robert A Vierkant, Lynn C Hartmann, et al.
Research Square|April 24, 2023
Vaccination with intravenous BCG protects macaques with pre-existing SIV infection from tuberculosisErica C Larson, Amy L Ellis-Connell, Mark A Rodgers, et al.
Blood|July 12, 2019
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemiaBrian Giacopelli, Qiuhong Zhao, Amy S Ruppert, et al.
Blood Cancer Journal|April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genesNicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Molecular Genetics & Genomic Medicine|September 26, 2017
Targeted sequencing of 36 known or putative colorectal cancer susceptibility genesMelissa S DeRycke, Shanaka Gunawardena, Jessica R Balcom, et al.
Blood Advances|February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort StudyJia Ruan, Zhengming Chen, Melissa C Larson, et al.
American Journal of Hematology|February 7, 2025
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort StudySamuel Yamshon, Jean L Koff, Melissa C Larson, et al.
Nature|September 24, 2025
In vivo CRISPR screens identify modifiers of CAR T cell function in myelomaNelson H Knudsen, Giulia Escobar, Felix Korell, et al.
Cell Reports. Medicine|January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancerDongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Pageof 80